These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4313847)

  • 21. Conformational studies on modified proteins and peptides. VII. Conformation of epsilon-prototoxin and epsilon-toxin from Clostridium perfringens. Conformational changes associated with toxicity.
    Habeeb AF; Lee CL; Atassi MZ
    Biochim Biophys Acta; 1973 Oct; 322(2):245-50. PubMed ID: 4358084
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunopurification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Bird RA; Low MG; Stephen J
    FEBS Lett; 1974 Aug; 44(3):279-81. PubMed ID: 4370089
    [No Abstract]   [Full Text] [Related]  

  • 23. A highly efficient solid-phase radioimmune assay for a clostridial toxin.
    Lieberman M
    Anal Biochem; 1975 Jul; 67(1):115-21. PubMed ID: 167605
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study of the effect of Cl. sporogenes proteinases on the hemolytic activity of Cl. perfringens type A toxin].
    Zhak SP; Datsenko MF
    Mikrobiol Zh; 1968; 30(6):566-8. PubMed ID: 4308969
    [No Abstract]   [Full Text] [Related]  

  • 25. Clostridium perfringens type D epsilon prototoxin. Some chemical, immunological and biological properties of a highly purified prototoxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):143-9. PubMed ID: 4369870
    [No Abstract]   [Full Text] [Related]  

  • 26. [Extraction of dry concentrated toxin from Cl. perfringens type E].
    Zemlianitskaia EP; Samsonova VS
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):94-8. PubMed ID: 4308596
    [No Abstract]   [Full Text] [Related]  

  • 27. [Composition of nutrient media and toxin formation of Clostridium perfringens].
    Urguev KR
    Veterinariia; 1974 Mar; 3(0):46-7. PubMed ID: 4365136
    [No Abstract]   [Full Text] [Related]  

  • 28. [Isolation of the theta-hemolysin of Cl. perfringens].
    Dolgikh MS; Blagoveshchenskiĭ VA; Sergeeva TI; Novoselova GN
    Vopr Med Khim; 1981; 27(1):129-32. PubMed ID: 6258318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The toxins of Clostridium perfringens type C].
    Nedialkov S; Peichev B
    Vet Med Nauki; 1974; 11(2):73-8. PubMed ID: 4370604
    [No Abstract]   [Full Text] [Related]  

  • 30. Biological activities contaminating preparations of phospholipase C ( -toxin) from Clostridium perfringens.
    Möllby R; Nord CE; Wadström T
    Toxicon; 1973 Feb; 11(2):139-47. PubMed ID: 4351816
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of Cl. perfringens lecithinase in the effect of the toxin on tissue cultures].
    Shamraeva SA; Shemanova GF; Vlasova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Oct; 43(10):20-4. PubMed ID: 4305232
    [No Abstract]   [Full Text] [Related]  

  • 32. The nature of bacterial toxins.
    Bergdoll MS
    Clin Toxicol; 1972; 5(4):441-51. PubMed ID: 4345047
    [No Abstract]   [Full Text] [Related]  

  • 33. Medium for toxin production by Clostridium perfringens in continuous culture.
    Chou G
    Appl Microbiol; 1971 May; 21(5):794-8. PubMed ID: 4324884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Localization of phosphatases in Clostridium perfringens cells].
    Kachelkina AI; Kushnarev VM; Blagoveshchenskiĭ VA
    Dokl Akad Nauk SSSR; 1967 May; 174(3):700-3. PubMed ID: 4317618
    [No Abstract]   [Full Text] [Related]  

  • 35. Purification of staphylococcal alpha toxin by electrofocusing.
    Goode RL; Baldwin JN
    Prep Biochem; 1973; 3(4):349-61. PubMed ID: 4795835
    [No Abstract]   [Full Text] [Related]  

  • 36. [Observations of potentiation of toxins of Clostridium perfringens and Clostridium histolyticum].
    Mitskevich AI
    Mikrobiol Zh; 1967; 29(2):125-9. PubMed ID: 4308692
    [No Abstract]   [Full Text] [Related]  

  • 37. [A study of the soluble antigens of strains of Cl. perfringens isolated from the feces of healthy persons].
    Goeva OE; Borovik EB; Sidorenko GI
    Zh Mikrobiol Epidemiol Immunobiol; 1968 May; 45(5):43-6. PubMed ID: 4308712
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study of acid soluble phosphate compounds from Clostridium perfringens].
    Maĭorova IP; Blagoveshchenskiĭ VA
    Biokhimiia; 1967; 32(2):329-36. PubMed ID: 4298442
    [No Abstract]   [Full Text] [Related]  

  • 39. Enzymatic activation of Clostridium perfringens epsilon prototoxin and some biological properties of activated toxin.
    Worthington RW; Mülders MS; Van Rensburg JJ
    Onderstepoort J Vet Res; 1973 Dec; 40(4):151-4. PubMed ID: 4369993
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of passage on the fatty acid composition of the lipids in Clostridium perfringens A].
    Siniak KM; Rudichenko VF; Iaroshenko MN
    Mikrobiol Zh (1978); 1982; 44(1):25-8. PubMed ID: 6280021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.